ABSTRACT
OBJECTIVES: Compressed sensing allows for image reconstruction from sparsely sampled k-space data, which is particularly useful in dynamic contrast enhanced MRI (DCE-MRI). The aim of the study was to assess the diagnostic value of a volume-interpolated 3D T1-weighted spoiled gradient-echo sequence with variable density Cartesian undersampling and compressed sensing (CS) for head and neck MRI. METHODS: Seventy-one patients with clinical indications for head and neck MRI were included in this study. DCE-MRI was performed at 3 Tesla magnet using CS-VIBE (variable density undersampling, temporal resolution 3.4 s, slice thickness 1 mm). Image quality was compared to standard Cartesian VIBE. Three experienced readers independently evaluated image quality and lesion conspicuity on a 5-point Likert scale and determined the DCE-derived time intensity curve (TIC) types. RESULTS: CS-VIBE demonstrated higher image quality scores compared to standard VIBE with respect to overall image quality (4.3 ± 0.6 vs. 4.2 ± 0.7, p = 0.682), vessel contour (4.6 ± 0.4 vs. 4.4 ± 0.6, p < 0.001), muscle contour (4.4 ± 0.5 vs. 4.5 ± 0.6, p = 0.302), lesion conspicuity (4.5 ± 0.7 vs. 4.3 ± 0.9, p = 0.024) and showed improved fat saturation (4.8 ± 0.3 vs. 3.8 ± 0.4, p < 0.001) and movement artifacts were significantly reduced (4.6 ± 0.6 vs. 3.7 ± 0.7, p < 0.001). Standard VIBE outperformed CS-VIBE in the delineation of pharyngeal mucosa (4.2 ± 0.5 vs. 4.6 ± 0.6, p < 0.001). Lesion size in cases where a focal lesion was identified was similar for all readers for CS-VIBE and standard VIBE (p = 0.101). TIC curve assessment showed good interobserver agreement (k=0.717). CONCLUSION: CS-VIBE with variable density Cartesian undersampling allows for DCE-MRI of the head and neck region with diagnostic, high image quality and high temporal resolution.
ABSTRACT
Lymphatic spread determines treatment decisions in prostate cancer (PCa) patients. 68Ga-PSMA-PET/CT can be performed, although cost remains high and availability is limited. Therefore, computed tomography (CT) continues to be the most used modality for PCa staging. We assessed if convolutional neural networks (CNNs) can be trained to determine 68Ga-PSMA-PET/CT-lymph node status from CT alone. In 549 patients with 68Ga-PSMA PET/CT imaging, 2616 lymph nodes were segmented. Using PET as a reference standard, three CNNs were trained. Training sets balanced for infiltration status, lymph node location and additionally, masked images, were used for training. CNNs were evaluated using a separate test set and performance was compared to radiologists' assessments and random forest classifiers. Heatmaps maps were used to identify the performance determining image regions. The CNNs performed with an Area-Under-the-Curve of 0.95 (status balanced) and 0.86 (location balanced, masked), compared to an AUC of 0.81 of experienced radiologists. Interestingly, CNNs used anatomical surroundings to increase their performance, "learning" the infiltration probabilities of anatomical locations. In conclusion, CNNs have the potential to build a well performing CT-based biomarker for lymph node metastases in PCa, with different types of class balancing strongly affecting CNN performance.
Subject(s)
Deep Learning , Membrane Glycoproteins/administration & dosage , Organometallic Compounds/administration & dosage , Positron Emission Tomography Computed Tomography , Prostatic Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Aged , Gallium Isotopes , Gallium Radioisotopes , Humans , Lymphatic Metastasis , Male , Prostatic Neoplasms/pathology , Retrospective StudiesABSTRACT
BACKGROUND: A revised version of the PI-RADS scoring system has been introduced and score-related variability between version 1 and 2 may be suspected. This study aimed to assess the PI-RADS scores derived from version 1 (v1) and the updated version 2 (v2). MATERIAL AND METHODS: 61 patients with biopsy-proven prostate cancer (PCa) and 90 lesions detected on pre-biopsy 3-Tesla multiparametric MRI were included in this retrospective analysis. 2 experienced radiologists scored all lesions in consensus. Lesion scores differing between PI-RADS v1 and v2 were further analyzed. Histology data from radical prostatectomy (RP) were included when available. RESULTS: The PI-RADS v1 and v2 score differed in 52% of patients (32/61) and in 39% of lesions (35/90). On a lesion basis, the reason for the differences were related to sum score in v1 vs. categorical system in v2 in 51% (18/35) of lesions, cutoff between PI-RADS 4 and 5 based on lesion size in v2 as opposed to the sum score in v1 in 31% (11/35) and were inconclusive in 17% (6/35). The RP subgroup indicates enhanced detection of PCas with GS 3+3 and GS 3+4 in v2. CONCLUSION: PI-RADS scores of prostatic lesions frequently differed between v1 and v2, the major reasons for these differences being score-related. In men undergoing RP, PI-RADS v2 improved detection of low risk PCa, but did not increase accuracy for discrimination of GS 3+4 vs. GS≥4+3 compared to v1. Urologists should be aware of the system-related differences when interpreting PI-RADS scores.
Subject(s)
Magnetic Resonance Imaging , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Aged , Biopsy , Humans , Male , Middle Aged , Prostate/diagnostic imaging , Prostate/pathology , Prostatectomy , Prostatic Neoplasms/surgery , Retrospective StudiesABSTRACT
PURPOSE: To investigate the safety and feasibility of the use of a vascular closure device (VCD) after endovascular procedures in swine. MATERIAL AND METHODS: In a study on endovascular therapy, VCD (StarClose, Abbott Vascular, Il, USA) was used in 20 female swines to achieve immediate hemostasis after percutaneous right femoral artery (FA) access. 10 animals were sacrificed immediately after the study and 10 animals were sacrificed 28 days after the initial study. To ensure complete hemostasis and patency of the femoral artery, a CT-angiography of the puncture site was performed on day 1 (acute and chronic group) and day 28 (chronic group). After the sacrifice, the femoral artery was explanted and examined macroscopically for signs of VCD dysfunction. RESULTS: Technical success rate was 100% with immediate hemostasis being achieved in all animals. No animals showed evidence of hematoma. During explantation, only small traces of coagulated blood were found in the acute group, while there were no signs of hematoma in the chronic group. CT-angiography immediately after VCD application as well as before sacrifice (chronic group) showed patency of the FA in all cases. CONCLUSION: The use of VCD to achieve hemostasis after endovascular studies in swine is feasible and safe.
Subject(s)
Endovascular Procedures/methods , Vascular Closure Devices , Animals , Female , Femoral Artery/surgery , Hematoma/prevention & control , SwineABSTRACT
PURPOSE: To evaluate heating efficacy of superparamagnetic iron oxide nanoparticles (SPIO) for electromagnetic ablation (EMA) of osteoid osteoma (OO) using an ex vivo model compared to radiofrequency ablation (RFA) and microwave ablation (MWA). METHODS: A model for OO using sliced bovine tibia and sliced muscle tissue was developed. A bone cavity filled with either a mixture of SPIO and agarose or pure agarose (control group) was established. EMA was performed using an experimental system, RFA and MWA using clinically approved systems, and the ablation protocols recommended by the vendor. For temperature measurements, fiberoptic temperature probes were inserted inside the cavity, on the outside of the periosteum, and at a 5 mm distance to the periosteum. RESULTS: Maximum temperatures with or without SPIO in the nidus were as follows: EMA: 79.9 ± 2.5/22.3 ± 0.7 °C; RFA: 95.1 ± 1.8/98.6 ± 0.9 °C; MWA: 85.1 ± 10.8/83.4 ± 9.62 °C. In RFA with or without SPIO significantly higher temperatures were achieved in the nidus compared to all other groups (p < 0.05). In MWA significantly higher temperatures were observed in the 5 mm distance to the periosteum compared to EMA and RFA with or without SPIO (p < 0.05). In MWA temperature decrease between nidus and the 5 mm distance to the periosteum was significantly lower than in RFA with or without SPIO (p < 0.0001). In MWA without SPIO temperature decrease was significantly lower than in the EMA group (p < 0.05). CONCLUSION: In the experimental setting, ablation of OO is safe and effective using EMA. It is less invasive than RFA and MWA, and it theoretically allows repeated treatments without repeated punctures. In comparison, the highest temperatures in the nidus are reached using RFA.
Subject(s)
Catheter Ablation/methods , Dextrans/pharmacology , Microwaves/therapeutic use , Osteoma, Osteoid/surgery , Animals , Cattle , Disease Models, Animal , Electromagnetic Fields , Equipment Design , Magnetite Nanoparticles , Temperature , TibiaABSTRACT
AIM: Before clinical implementation of an approved electromagnetic tracking system (CAPPA IRAD EMT) an experimental trial was performed to investigate the accuracy of the system and its safety in application for transpedicular vertebral punctures in comparison to the classical fluoroscopic method. MATERIAL AND METHODS: A total of 110 transpedicular punctures were performed bilaterally using 11 vertebrae of 5 realistic artificial phantoms and 1 pedicle was punctured with the conventional technique using c-arm fluoroscopy and the other with the electromagnetic tracking system. As a target a radiopaque non-ferromagnetic marker was implanted bilaterally in the anterior wall of the vertebrae. For evaluation of the precision the distance from the end of the puncture to the target and the gradual deviation of the actual channel from the ideal trajectory were assessed in three-dimensional computer tomography. Calculations and statistical analysis were performed according to the Wilcoxon test by means of SPSS 16.0.1 for Windows. RESULTS: The mean distance from the target was 6.6 mm (± 3.9 mm standard deviation SD) with electromagnetic navigation compared to 3.2 mm (± 2.8 mm SD) with fluoroscopic assistance and the mean aberration from the ideal trajectory was 18.4° (± 4.6° SD) compared to 6.5° (± 3.5° SD), respectively. The difference of accuracy was highly significant regarding both parameters (p < 0.001). CONCLUSIONS: The minimum requirement for accuracy of transpedicular punctures could not be achieved with electromagnetic navigation. Unless proven otherwise, the lack of accuracy is attributed to unstable referencing. Despite evidence of successful employment for soft tissue punctures the system cannot currently be recommended for osseous applications of the spine.
Subject(s)
Magnetics/instrumentation , Magnetics/methods , Punctures/instrumentation , Punctures/methods , Spine/surgery , Surgery, Computer-Assisted/instrumentation , Surgery, Computer-Assisted/methods , Electromagnetic Fields , Equipment Design , Equipment Failure Analysis , Humans , In Vitro Techniques , Spine/diagnostic imaging , Tomography, X-Ray Computed/methodsABSTRACT
PURPOSE: To systematically investigate the impact of image acquisition and contrast injection parameters for CO2-enhanced CT angiography (CTA) of the aorto-iliac and peripheral arteries in a pig model using commercially available equipment. The aim was to establish an imaging protocol that is ready for use in human subjects. MATERIALS AND METHODS: Three domestic swine underwent CO2-CTA with varying injection parameters: pitch (1.0, 3.0), injection pressure (0.7 bar, 1.0 bar, 1.3 bar) and scan delay (2 s, 4 s, 6 s). Objective (vessel diameter) and subjective (image quality) parameters and applied radiation doses were systematically evaluated. To ensure clinical applicability of the setting, only approved catheters/injectors and standard injection parameters were evaluated. RESULTS: The image quality scores were superior and the vessel diameter was larger with high pitch in comparison to standard pitch (diameters: 4.7 ± 2.0 mm vs. 3.6 ± 2.1 mm, p = 0.0040, scores: 2.6 ± 1.1 vs. 2.0 ± 1.1, p = 0.0038). High injection pressure (1.3 bar) improved the image quality as assessed by subjective and objective ratings (diameters: 3.6 ± 2.0 mm, 4.0 ± 2.1 mm and 4.6 ± 2.1 mm, for 0.7, 1.0 and 1.3 bar, p-values ≤ 0.0052, scores: 1.9 ± 1.1, 2.3 ± 1.1 and 2.7 ± 1.2, p-values ≤ 0.0017), the same was observed for a shorter injection delay (diameters: 3.5 ± 2.0 mm, 4.2 ± 2.1 mm and 4.8 ± 2.1 mm, for 6 s, 4 s, and 2 s, p ≤ 0.0022, scores: 1.9 ± 1.1, 2.3 ± 1.1 and 2.7 ± 1.1, p-values ≤ 0.0013). The dose length products were 239 ± 47 mGycm (high pitch) and 565 ± 63 mGycm (standard pitch, p-values < 0.0001). CONCLUSION: A higher pitch, shorter delay and higher injection pressure improve image quality in CO2-enhanced CTA. Since commercially available, clinically approved equipment was used. The protocol is now ready for use in human subjects.
Subject(s)
Angiography/methods , Carbon Dioxide/administration & dosage , Contrast Media/administration & dosage , Radiographic Image Enhancement/methods , Tomography, X-Ray Computed/methods , Animals , Dose-Response Relationship, Drug , Models, Animal , Pressure , Reproducibility of Results , Sensitivity and Specificity , SwineABSTRACT
PURPOSE: Evaluation of the maximum temperatures and ablation volumes in microwave ablation (MWA) after injection of different concentrations of silicon carbide (SiC) particles in an ex-vivo bovine liver model. MATERIALS AND METHODS: 15 ml of different concentrations of SiC particles (20 vol% SiC; 50 vol% SiC) mixed with 2 % gelatin were injected into an ex-vivo bovine liver. As a reference group, 2 % gelatin without SiC was injected. MWA was performed using a clinical MWA system with different generator settings (10 - 45 W/10 minutes). The temperature was measured at a distance of 5 mm and 10 mm from the applicator. Afterwards the liver tissue was sliced along the short and long axis, the ablation zones were measured on the x, y and z-axis and the ablation volume was calculated. All experiments were performed 5 times (total: 40 experiments). RESULTS: The average maximum temperatures measured at a generator setting of 45 W at a distance of 5 mm from the applicator were 103.4 ± 4.6 °C (20 vol% SiC), 103.3 ± 6.5 °C (50 vol% SiC) and 96.0 ± 4.2 °C in the control group (0 vol% SiC). At 45 W, injection of 20 vol% SIC caused a significantly higher maximum temperature than that achieved in the control group (p = 0.016). No significant temperature increase compared to the control group could be measured using 50 vol% SiC. The mean ablation volumes at 45 W and 20 vol% SiC and 50 vol% SiC were significantly larger (172.7 ± 31.5 ml and 171.0 ± 34.7 ml, respectively) than those achieved in the control group (111.2 ± 23.8 ml) (p = 0.027 and p = 0.045). CONCLUSION: In an ex-vivo bovine liver model, the SiC particles demonstrated an enhancing effect of MWA with respect to maximum temperatures and ablation volume. Therefore, SiC is a promising candidate for enhancing MWA in vivo.
Subject(s)
Biocompatible Materials , Carbon Compounds, Inorganic/administration & dosage , Catheter Ablation/instrumentation , Catheter Ablation/methods , Disease Models, Animal , Liver/surgery , Silicon Compounds/administration & dosage , Animals , Cattle , Dose-Response Relationship, Drug , In Vitro Techniques , Injections , Microwaves , Particle Size , TemperatureABSTRACT
CLINICAL ISSUE: Primary and secondary liver tumors often limit patient outcome and only a minority of patients are eligible for potential curative surgery. Minimally invasive treatments, such as radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation are alternative treatment options in a curative and palliative setting. One major limitation of RFA and MWA is the limited size of tumor ablation. Furthermore during the procedure the ablation size can only be roughly estimated using RFA and MWA. STANDARD TREATMENT: RFA is the standard modality of minimally invasive tumor therapy. In comparison cryoablation is rarely used despite its advantages. TREATMENT INNOVATIONS: Argon-helium-based cryoablation systems of the newest generation combine the advantage of small diameter applicators comparable with those of RFA and MWA systems with intrinsic advantages. ACHIEVEMENTS: Cryoablation is a minimally invasive treatment option with advantages, such as virtually unlimited ablation size, real-time visualization using computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound and intrinsic analgesic effects. On the other hand it is not very time-efficient in comparison to MWA. Especially in liver metastases RFA is the preferred treatment option. PRACTICAL RECOMMENDATIONS: Cryoablation is a fascinating treatment option in minimally invasive tumor treatment. It demonstrates good results in hepatocellular carcinoma within the Milan criteria and T1a renal cell carcinoma. Furthermore it is a well-established treatment modality for palliative pain management in bone tumors.
Subject(s)
Cryosurgery/methods , Cryosurgery/trends , Minimally Invasive Surgical Procedures/methods , Minimally Invasive Surgical Procedures/trends , Neoplasms/surgery , HumansABSTRACT
PURPOSE: To quantitatively analyze differences in mechanical properties, needle design including signs of wear, subjective handling and specimen quality of bone biopsy needles. MATERIALS AND METHODS: In this study 19 different bone biopsy systems (total 38; 2 /type) were examined. With each biopsy needle five consecutive samples were obtained from vertebral bodies of swine. During puncture a force-torques sensor measured the mechanical properties and subjective handling was assessed. Before and after each biopsy the needles were investigated using a profile projector and signs of wear were recorded. Afterwards, a pathologist semi-quantitatively examined the specimen regarding sample quality. The overall evaluation considered mechanical properties, needle wear, subjective handling and sample quality. Differences were assessed for statistical significance using ANOVA and t-test. RESULTS: Needle diameter (p = 0.003) as well as needle design (p = 0.008) affect the mechanical properties significantly. Franseen design is significantly superior to other needle designs. Besides, length reduction recorded by the profile projector, as a quality criterion showed notable distinctions in between the needle designs. CONCLUSION: Bone biopsy needles vary significantly in performance. Needle design has an important influence on mechanical properties, handling and specimen quality. Detailed knowledge of those parameters would improve selecting the appropriate bone biopsy needle.
Subject(s)
Biopsy, Needle/instrumentation , Bone Diseases/pathology , Bone and Bones/pathology , Equipment Design , Mechanical Phenomena , Radiology, Interventional/instrumentation , Spine/pathology , Tomography, X-Ray Computed/instrumentation , Animals , Equipment Failure , Needles , Surface Properties , SwineABSTRACT
PURPOSE: Silicon carbide (SiC) is an inert compound material with excellent microwave absorption and heat-conducting properties. The aim of our study was to investigate the heat-enhancing effects of SiC in microwave ablation in an in vitro setting. MATERIALS AND METHODS: Different concentrations of SiC powder were mixed with 2% gelatin, producing a 20-ml mixture that was then heated with a clinical microwave ablation system (5 min/45 W). Temperature was measured continuously fiberoptically. Additional heating properties were assessed for the most heatable concentrations at different energy settings (10, 20, and 30 W). As reference, 2% gelatin without SiC was heated. Statistical evaluation by analysis of variance with post hoc Student-Newman-Keuls testing was performed. RESULTS: For the different SiC concentrations, maximum temperatures measured were 45.7 ± 1.2°C (0% SiC, control), 50.4 ± 3.6°C (2% SiC), 60.8 ± 1.8°C (10% SiC), 74.9 ± 2.6°C (20% SiC), and 83.4 ± 2.5°C (50% SiC). Differences between all data points were significant (P < 0.05). Maximum temperatures that used 20% SiC were 36.3 ± 2.76°C (10 W), 48.7 ± 4.18°C (20 W), and 50.6 ± 0.68°C (30 W). The use of 50% SiC maximum temperatures resulted in values of 46.2 ± 2.52°C (10 W), 70.1 ± 0.64°C (20 W), and 83.0 ± 4.69°C (30 W). With 20% SiC and 50% SiC mixtures, the 10 W maximum temperatures were significantly lower than at all other power levels, and maximum temperatures with 20 and 30 W were significantly lower when compared with 45 W (P < 0.05). CONCLUSIONS: SiC is a nontoxic, highly effective substance for enhancing microwave-induced heating with a microwave ablation system in vitro. These data suggest its usefulness for enhancement of ablative effects in percutaneous tumor therapy. Further investigations need to be performed to evaluate the ex vivo and in vivo ablation effects and the possible methods for administration of SiC particles.
Subject(s)
Biocompatible Materials , Carbon Compounds, Inorganic , Hyperthermia, Induced/instrumentation , Microwaves/therapeutic use , Silicon Compounds , Gelatin , In Vitro Techniques , TemperatureABSTRACT
PURPOSE: Evaluation of the enhancing or protecting effects of different fluids during microwave ablation (MWA). MATERIALS AND METHODS: 3 samples of 17 different fluids (each 20 ml) were heated using MWA at power levels of 10, 20, 30, 40 and 45 watts. Energy was applied until the temperature reached 80 degrees C or the duration of heating exceeded 10 minutes. The cooling-down process was then observed until the temperature reached 30 degrees C. RESULTS: Gastrografin needed the shortest time to be heated up to 80 degrees C (370 sec), followed by Magnograf (410 sec) and HES 10 % (420 sec). The least heatable fluids were Lipiodol (10 min -54.5 +/- 2.43 degrees C), distilled water (10 min -56 +/- 2.42 degrees C) and Glucose 5 % solution (10 min -56.6 +/- 1.69 degrees C). Fluids which could not be heated well, such as distilled water, Lipiodol or Glucose 5 % solution, had a small slope of the temperature curve as a function of the power level used (m = 0.60 - 0.73), whereas fluids which could be heated well, such as Gastrografin, Magnograf and HES 10 %, had a much steeper slope of the temperature curve as a function of the power level (m = 0.99 - 1.20). With respect to the maximum temperature, the above mentioned groups differed significantly (p < 0.05). The temperature slope correlated strongly with maximum temperatures reached (Pearson correlation coefficient: 0.97). CONCLUSION: By additionally administering a carefully chosen fluid, enhancing or protecting effects during microwave ablation can be observed. Especially Gastrografin, Magnograf and HES 10 % can be used to enhance ablation effects, whereas protective effects can be observed particularly when using Lipiodol, distilled water and Glucose 5 %-solution.
Subject(s)
Electrocoagulation/methods , Microwaves/therapeutic use , Neoplasms/surgery , Contrast Media , Diatrizoate Meglumine , Gadolinium DTPA , Glucose Solution, Hypertonic , Heating , Humans , In Vitro Techniques , Injections , Iodized Oil , Preoperative Care , Solutions , Temperature , WaterABSTRACT
PURPOSE: Osteoid osteoma is a benign primary bone tumor that typically occurs in children and young adults. Besides local pain, which is often worse at night, prompt relief due to medication with acetylsalicylic acid (ASS) is characteristic for this bone lesion. Because long-term medication with ASS does not represent an alternative treatment strategy due to its potentially severe side effects, different minimally invasive image-guided techniques for the therapy of osteoid osteoma have been developed. In this context radiofrequency (RF) ablation in particular has become part of the clinical routine. The technique and results of image-guided RF ablation are compared to alternative treatment strategies. MATERIALS AND METHODS: Using this technique, an often needle-shaped RF applicator is percutaneously placed into the tumor under image guidance. Then a high-frequency alternating current is applied by the tip of the applicator which leads to ionic motion within the tissue resulting in local heat development and thus in thermal destruction of the surrounding tissue including the tumor. RESULTS: The published primary and secondary success rates of this technique are 87 and 83 %, respectively. Surgical resection and open curettage show comparable success rates but are associated with higher complication rates. In addition image-guided RF ablation of osteoid osteomas is associated with low costs. CONCLUSION: In conclusion image-guided RF ablation can be considered the gold standard for the treatment of osteoid osteoma.